SCHEMBL6133504

SCHEMBL6133504

CC(C)n1nc(-c2sc(C(=O)NC3CC3)nc2-c2ccccc2F)ccc1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LCK P06239 1/20 0.38
KIT P10721 1/20 0.38
KDR P35968 1/20 0.38
MAPK14 Q16539 1/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
GAA P10253 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HPGDS O60760 2/20 0.38
MAOB P27338 1/20 0.37
HTR4 Q13639 1/20 0.36
SMYD3 Q9H7B4 1/20 0.35
DGAT1 O75907 1/20 0.35
RIPK1 Q13546 1/20 0.35
LIPG Q9Y5X9 3/20 0.35
WNT1 P04628 2/20 0.35
DYRK1A Q13627 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6133760 0.88 MAOB (0.40) KMT2AMEN1ALDH1A1MAOBHTR4
SCHEMBL6134156 0.87 TSHR (0.42) KDM4EALDH1A1HSD17B10DYRK1A
SCHEMBL6133269 0.86 HPGD (0.42) KDM4EALDH1A1MAPK1HPGDSSMYD3
SCHEMBL6134062 0.85 MAP4K4 (0.41) KMT2AHPGDSSMYD3DYRK1ARORC
SCHEMBL6133755 0.84 CDC7 (0.37) ALDH1A1HSD17B10DYRK1A
SCHEMBL6133631 0.84 MAOB (0.47) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL6133317 0.81 MAPT (0.46) MAPK14KDM4EALDH1A1MAPK1
SCHEMBL6133825 0.81 ADORA2A (0.46) KMT2AMEN1KDM4EALDH1A1MAPK1
SCHEMBL6133353 0.80 ALDH1A1 (0.47) KMT2AMEN1KDM4EALDH1A1GAA
SCHEMBL6133426 0.78 TGFBR1 (0.45) MAPK14KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof ASTELLAS PHARMA INC. (JP) 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004134-A1 Thiazole derivative and pharmaceutical use thereof MC2R, CYP2C9, OXTR LCK 1361/4885KIT 3360/4885KDR 1091/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.